Again, the majority of patients enrolled were systemic ALCL (n = 316, ALK-negative: n = 218, ALK-positive: n = 98); however, PTCL-NOS (n = 72) and AITL (n = 54) were represented. Here, ALK is linked to angioimmunoblastic T-cell lymphoma.